AA
AlphaCentric Advisors’s Jazz Pharmaceuticals JAZZ Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-15,500
| Closed | -$1.73M | – | 251 |
|
|
2024
Q3 | $1.73M | Buy |
15,500
+4,500
| +41% | +$501K | 1.28% | 24 |
|
|
2024
Q2 | $1.17M | Buy |
11,000
+2,500
| +29% | +$267K | 0.86% | 40 |
|
|
2024
Q1 | $1.02M | Sell |
8,500
-2,000
| -19% | -$241K | 0.62% | 61 |
|
|
2023
Q4 | $1.29M | Sell |
10,500
-16,000
| -60% | -$1.97M | 0.87% | 43 |
|
|
2023
Q3 | $3.43M | Sell |
26,500
-14,250
| -35% | -$1.84M | 1.95% | 7 |
|
|
2023
Q2 | $5.05M | Buy |
40,750
+33,750
| +482% | +$4.18M | 2.8% | 1 |
|
|
2023
Q1 | $1.02M | Buy |
7,000
+3,500
| +100% | +$512K | 0.71% | 49 |
|
|
2022
Q4 | $558K | Hold |
3,500
| – | – | 0.55% | 66 |
|
|
2022
Q3 | $467K | Buy |
+3,500
| New | +$467K | 0.48% | 61 |
|
|
2021
Q4 | $1.27M | Buy |
+10,000
| New | +$1.27M | 0.37% | 19 |
|
|
2020
Q4 | – | Sell |
-350
| Closed | -$50K | – | 219 |
|
|
2020
Q3 | $50K | Sell |
350
-275
| -44% | -$39.3K | 0.02% | 107 |
|
|
2020
Q2 | $69K | Buy |
+625
| New | +$69K | 0.04% | 70 |
|